Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting The Rise of Patient Advocacy By Juliet Moritz March 28, 2017 Patient and Stakeholder Engagement The Future of Patient Advocacy and Orphan Drug Development: Challenges and Opportunities By Juliet Moritz February 28, 2017 Consulting NORD Summit, a Rare Disease Regulatory Wonderland By Juliet Moritz October 26, 2016 Tales from the Road – Orphan Drugs Summit in Amsterdam By Juliet Moritz October 14, 2016 Previous 1 2 × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Premier Voices #2: Registry Studies & Natural...